PhD fellows

PhD fellows 2013

  • Andreas Brønden Petersen, MD - Physiological mechanisms behind sevelamer’s effect on glucose metabolism

  • Angela Estampedor, MSc - Pregnancy and early life origin of metabolic disease 

  • Anja Elaine Sørensen, MSc - MicroRNA biomarkers of insulin resistance and reduced fertility in women with polycystic ovary syndrome

  • Ann Bjørnshave, MSc - Whey protein, postprandial lipidemia and cardiovascular disease: Evaluation of the effect of a pre-meal of whey protein on postprandial lipidemia in persons with the metabolic syndrome and type 2 diabetes

  • Anna Maria Kaufmann Lindqvist, MSc - Skeletal muscle angiogenesis in type 2 diabetes and its relation to insulin sensitivity

  • Annemarie Lundsgaard, MSc - Dietary fatty acids and insulin sensitivity: regulatory mechanisms

  • Anne-Sofie Bøgh Larsen, BSc - Transcription factors involved in defining brown and brown-in-white adipocyte gene programs

  • Clea Bruun Johansen, MSc - Type 1 diabetes in the family: An exploratory study of family challenges and resilience
    actors and their translation into a research based framework for family interventions

  • Ditte Søgaard, MSc - The influence of training and age on human muscle bioactive lipids and coupling to insulin resistance

  • Ditte Sørensen, MSc - FoxO target genes regulated by insulin in endothelial cells as determinants of atherosclerosis in type 2 diabetes

  • Freja Bach Kampmann, MSc - Fetal exposure to tobacco smoking and diabetes - what are the cardio-metabolic consequences for the offspring?

  • Johanne Agerlin Windeløw, MSc - Glucose-dependent insulintropic polypeptide – an energy storage hormone
  • Kamilla Winding, MSc - The role of nucleotides in the impaired blood flow in people with type II diabetes: optimising the recommendations for exercise training as a treatment

  • Katrine Lawaetz Kristensen, MD - The paradoxical protective role of diabetes mellitus in the development and progression of atherosclerotic abdominal aortic aneurysms

  • Kristian Honnes de Lichtenberg, MSc - Mechanisms of beta-cell progenitor formation

  • Line Hjort, MSc - Epigenetic mechanisms in fetal programming by gestational diabetes

  • Manan Pareek, MD - Detection of early atherosclerosis and arteriosclerosis using biomarkers and PET/CT (DETECT) in healthy controls and patients with hypertension, T2D, or carotid artery stenosis: The relative importance of hemodynamic and metabolic factors for arterial inflammation, calcification and atherosclerosis

  • Marianne Dalsgaard Kristensen, MSc - Ectopic lipid depositions, skeletal muscle glycogen storage and chronic inflammation and its relation to insulin sensitivity during insulin resistance remission after gastric by-pass surgery

  • Mathilde Svenstrup, MD - Are genetic variants in the Inhibitor of differentiation-3 (ID3) associated with clinical and biochemical measures related to development of obesity, insulin resistance, type 2 diabetes and cardiovascular disease?

  • Mette Yde, MSc - The role of small non-coding RNAs and nuclear hormone receptors in non-alcoholic fatty liver disease

  • Michael Christensen, BSc - The effect of metformin on impaired renal function in response to complex kidney diseases

  • Michael Vaeggemose, MSc - MR diagnostics of diabetic peripheral neuropathy

  • Rikke Møller Hjortebjerg, MSc - Metabolic functions of the IGF-system in human adipose tissue

  • Rok Kosmina, MSc - The role of delta-like 1 (DLK1) in obesity and metabolic syndrome

  • Sascha Pilemann-Lyberg, MD - Uric acid and its role in initiation of diabetic nephropathy and cardiovascular disease in patients with diabetes

  • Sisse Heiden, MSc - A model-based information and communication system to help diabetic kidney patients cope with diet restrictions

  • Sofie Traynor, MSc - Function and genomic interactome of early adipogenic transcription factor hotspots

  • Therese Juhlin Larsen, MSc - Recruitment of human brown fat – an anti-diabetes strategy? 

PhD fellows 2014

  • Adrija Kalvisa - A genomics approach to identify transcriptional signalling networks regulating hepatic response to feeding

  • Ajenthen Ranjan - Dual-hormone treatment in type 1 diabetes

  • Alireza Kashani Pour - Machine learning methods for elucidating the role of gut microbiome in type 2 diabetes

  • Amelie Cleo Keller - Prenatal exposure to vitamin D fortified food and risk of type 2 diabetes later in life

  • Anne Bo - Development of a complex evidence- and theory-based intervention for type 2 diabetes management among young adults (aged 20–40 years)

  • Caroline Maag Kristensen - Impact of exercise training on hepatic ER stress

  • Cecilie Nandrup Bus - Role of long non-coding RNAs in metabolic function of human brown fat

  • Dorte Enggaard Kristensen - "Exercising" with insulin action

  • Esben Søvsø Szocska Hansen - Evaluation of the cardioprotective effects of remote ischemic conditioning in diabetic myocardial infarction by cardiovascular magnetic resonance and hyperpolarized [13C]

  • Eva Pers Winning Iepsen - Is a functional melanocortin-4 receptor (MC4R) essential for the appetite inhibiting effect of GLP-1? GLP-1 response and effect in obese adults diagnosed with obesity causal MC4R mutations

  • Gitte Øskov Skajaa - Insulin sensitivity during pregnancy and post partum

  • Han Chow Koh - The role of interactions and localization of mitochondria intramyocellular lipids and glycogen in type 2 diabetes mellitus - effects of physical training
  • Isabel Forss - Transcriptional networks involved in lineage determination and differentiation of brown adipocytes

  • Line Engelbrechtsen - Progression of type 2 diabetes: The role of pharmacogenetic interactions

  • Louise Lehrskov Schmidt - Effect of glucotoxicity on adaptations to physical activity in patients with type 2 diabetes

  • Mette Lundgren Nielsen - HOMA index – As a prognostic marker in the general population and as a marker of metabolic phenotype in type 2 diabetes mellitus – An ITT substudy (HOMAP-Metabolic)

  • Mette Søndergaard Nielsen - How does appetite regulation affect weight loss in severely obese insulin resistant subjects after Roux-en-Y gastric bypass (RYGB) surgery?

  • Monija Mrgan - Coronary plaque morphology and plaque progression in patients with newly diagnosed type-2 diabetes mellitus (DD2-plaque study)

  • Morten Dall - NAD-salvage systems in insulin sensitivity and mitochondrial function: Implications for Type 2 Diabetes

  • Naja Zenius Jespersen - Brown adipose tissue – implications for improving glucose tolerance in humans

  • Natasha Bergman - GIP/GLP-1 co-activity in subjects with obesity: Lowering of food intake

  • Pedram Shokouh - How coffee and its constituents affect the development of type 2 diabetes and non-alcoholic fatty liver disease – a comparison between coffee species and coffee-based supplements

  • Rie Dybboe - The role of hexokinase in regulation of insulin sensitivity in skeletal muscle of rodent and man. 
    Development of new methods to address an old problem

  • Rugivan Sabaratnam - Molecular effects of acute exercise and testosterone in skeletal muscle of patients with type 2 diabetes

  • Seyed Mojtaba Ghiasi - Oxidation and nitration of RNA as a cause of beta-cell failure in type 2 diabetes

  • Sten Vissing Fahnøe Hansen - Unraveling ubiqtuination dependent signaling in human health and diseases

  • Søren Madsen - Regulation of the miRNA processing machinery under metabolic challenges

  • Theresia Schnurr - The role of genetics on objectively measured physical activity and sedentary behavior and its association to obesity and diabetes related traits